TaiGen Biopharmaceuticals Holdings Limited (TPEX: 4157)

TaiGen Biopharmaceuticals Holdings Market Cap

TaiGen Biopharmaceuticals Holdings has a market cap or net worth of 10.41 billion as of September 10, 2024. Its market cap has decreased by -3.20% in one year.

• Market Cap: 10.41B
• Enterprise Value: 9.37B
• Revenue: 149.45M
• Ranking: n/a
• PE Ratio: 45.93
• Stock Price: 14.50

Market Cap Chart

Since September 5, 2013, TaiGen Biopharmaceuticals Holdings's market cap has decreased from 42.07B to 10.41B, a decrease of -75.26%. That is a compound annual growth rate of -11.90%.

Market Cap History

Date	Market Cap	% Change
Sep 10, 2024	10.41B	-4.61%
Dec 29, 2023	10.91B	-5.16%
Dec 30, 2022	11.51B	4.22%
Dec 30, 2021	11.04B	-32.60%
Dec 31, 2020	16.38B	24.19%
Dec 31, 2019	13.19B	8.25%